MONTELUKAST VIATRIS 10 mg, film-coated tablet 28 tablets, CIP 3400930201848
Active ingredients: Montelukast, Montelukast sodium
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet28 tablets, CIP 3400930201848orale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- MONTELUKAST VIATRIS 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène de 28 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Sept 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64723206CIP73020184CIP133400930201848Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MONTÉLUKASTcomprimé | 10 mg · un comprimé | FT |
| MONTÉLUKAST SODIQUEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.